Navigation Links
Researchers find anatomic differences after robotic-assisted radical prostatectomy
Date:4/11/2011

(Boston) Researchers from Boston University School of Medicine (BUSM) have concluded that the anatomy of the pelvis following robotic-assisted radical prostatectomy

(RARP) is considerably different when compared to the anatomy of the pelvis following an open prostatectomy (OP). These findings, which are the first to ever compare pelvic anatomy following RARP and OP surgery, may have implications for patients requiring post-operative radiation. The study currently appears on-line in Practical Radiation Oncology.

Prostate cancer is the most common non-cutaneous cancer diagnosed in men globally. In 2009, there were 192,280 new cases diagnosed, and 27,360 deaths from prostate cancer in the U.S. The surgical approaches to prostatectomy include open (OP), laparoscopic, and robot-assisted prostatectomy. In particular, robot-assisted prostatectomy has rapidly gained acceptance in the urologic community and is now in widespread and rapidly expanding use. Currently it is estimated that nearly 60 percent of all prostatectomies in the United States are performed using the robotic technique.

The role of postoperative radiation therapy has been well established. A 1992 randomized, multicenter phase III study by the European Organization for Research and Treatment of Cancer indicated biochemical progression-free survival was statistically significantly improved in the patients treated with adjuvant radiation therapy (74 percent) versus patients treated by radical prostatectomy alone (52.6 percent).

The researchers compared post-operative pelvic MRI scans on consecutive prostatectomy patients (15 RARP and 10 OP) measuring 13 distinct anatomic distances to determine differences in each of the parameters between RARP and OP.

According to the researchers the pelvic anatomy post-RARP is considerably different from the pelvic anatomy post-OP. "The most clinically relevant differences observed in the current study were the superior mediolateral separation of the levator ani and the trend toward statistical significance in the separation of the bladder from the rectum, representing the anterior, posterior, and lateral borders of treatment volumes," explained lead author Ariel Hirsch, MD, an assistant professor of radiation oncology at BUSM "Thus, careful attention must be paid in planning the posterior and lateral margins to ensure that coverage is sufficient in men who have undergone RARP. To that end, our data support that the CTV borders as suggested by the Radiation Therapy Oncology Group guidelines be expanded five mm beyond the anterior rectal wall posteriorly and five mm beyond the levator ani muscles laterally in men who have undergone RARP," she added.

The researchers believe that as RARP continues to become a more widespread surgical option for the management of localized prostate cancer, the radiation field design may need to be further adjusted.


'/>"/>

Contact: Gina DiGravio
gina.digravio@bmc.org
617-638-8480
Boston University Medical Center
Source:Eurekalert

Related medicine news :

1. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
2. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
3. Researchers discover new way to kill pediatric brain tumors
4. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
5. Researchers create drug to keep tumor growth switched off
6. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
7. GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen
8. Clemson researchers develop hands-free texting application
9. Researchers find biomarkers in saliva for detection of early-stage pancreatic cancer
10. Researchers chart genomic map spanning over 2 dozen cancers
11. Researchers discover second protective role for tumor-suppressor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: